Nanotherapeutics engineered to cross the blood-brain barrier for advanced drug delivery to the central nervous system

Cited 45 time in webofscience Cited 0 time in scopus
  • Hit : 3
  • Download : 0
Drug delivery to the brain remains challenging mainly due to the blood-brain barrier (BBB) that regulates the entrance of substances to the brain. Advances in nanotechnology have enabled the engineering of nanomedicines for biomedical applications including enhanced drug delivery into the brain. In this review, we describe strategies of nanomedicines engineered to traverse the BBB and deliver therapeutic molecules to target brain sites. We highlight the representative applications with materials including polymers, lipids, and inorganic elements for brain drug delivery. We finalize this review with the current challenges and future perspective of nanotherapeutics for advanced drug delivery to the brain. (C) 2019 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
Publisher
ELSEVIER SCIENCE INC
Issue Date
2019-05
Language
English
Article Type
Review
Citation

JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, v.73, pp.8 - 18

ISSN
1226-086X
DOI
10.1016/j.jiec.2019.01.021
URI
http://hdl.handle.net/10203/321745
Appears in Collection
ME-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 45 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0